Arena Capital Advisors’s Liminatus Pharma Warrants LIMNW Stock Holding History

Arena Capital Advisors’s Portfolio LIMNW Stock Details LIMNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.19K	Hold	29,166	–	–	﹤0.01%	20
2026 Q1	$1.17K	Hold	29,166	–	–	﹤0.01%	20
2025 Q4	$1.02K	Hold	29,166	–	–	﹤0.01%	18
2025 Q3	$4.32K	Hold	29,166	–	–	﹤0.01%	23
2025 Q2	$7K	Buy	+29,166	New	+$5.73K	0.01%	15

Arena Capital Advisors's LIMNW Position: Q2 2026 in Review

Arena Capital Advisors held its Liminatus Pharma Warrants (LIMNW) position steady in Q2 2026 at 29,166 shares worth $2.19K. The position accounts for ﹤0.01% of the portfolio, ranked #20.

Arena Capital Advisors first reported a position in LIMNW in Q2 2025 and has held it in 5 quarters since. The position peaked at $7K in Q2 2025. 1 fund tracked by Wall St. Rank holds LIMNW as of Q2 2026.

Arena Capital Advisors held 29,166 shares of Liminatus Pharma Warrants worth $2.19K as of Q2 2026.
Arena Capital Advisors left its Liminatus Pharma Warrants share count unchanged in Q2 2026.
Liminatus Pharma Warrants made up ﹤0.01% of Arena Capital Advisors's portfolio in Q2 2026, its #20 holding.
Arena Capital Advisors first reported a position in Liminatus Pharma Warrants in Q2 2025 and has held it in 5 quarters since.
Arena Capital Advisors's Liminatus Pharma Warrants position peaked at $7K in Q2 2025.
1 fund tracked by Wall St. Rank held Liminatus Pharma Warrants as of Q2 2026.

Based on Arena Capital Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.